Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Equities research analysts at SunTrust Banks lowered their Q3 2017 earnings per share (EPS) estimates for Cross Country Healthcare in a research note issued to investors on Thursday. SunTrust Banks analyst T. Sommer now anticipates that the business services provider will post earnings of $0.16 per share for the quarter, down from their prior forecast of $0.18. SunTrust Banks also issued estimates for Cross Country Healthcare’s Q4 2017 earnings at $0.23 EPS, FY2017 earnings at $0.60 EPS, Q3 2018 earnings at $0.23 EPS and Q4 2018 earnings at $0.28 EPS.

Cross Country Healthcare (NASDAQ:CCRN) last issued its quarterly earnings results on Wednesday, August 2nd. The business services provider reported $0.16 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.07. The company had revenue of $209.31 million for the quarter, compared to the consensus estimate of $209.92 million. Cross Country Healthcare had a return on equity of 12.78% and a net margin of 1.06%. The company’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.16 EPS.

TRADEMARK VIOLATION NOTICE: “SunTrust Banks Weighs in on Cross Country Healthcare, Inc.’s Q3 2017 Earnings (CCRN)” was published by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/08/07/suntrust-banks-weighs-in-on-cross-country-healthcare-inc-s-q3-2017-earnings-ccrn.html.

A number of other analysts have also recently issued reports on the company. Benchmark Co. cut their price objective on Cross Country Healthcare from $19.00 to $18.00 and set a “buy” rating for the company in a research report on Thursday, May 4th. BMO Capital Markets cut their price objective on Cross Country Healthcare from $18.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, May 5th. Zacks Investment Research raised Cross Country Healthcare from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. BidaskClub cut Cross Country Healthcare from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Finally, UBS AG reaffirmed a “buy” rating and issued a $15.00 price objective (down from $16.50) on shares of Cross Country Healthcare in a research report on Wednesday, June 14th. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $16.21.

Cross Country Healthcare (CCRN) opened at 12.01 on Monday. The firm has a 50-day moving average price of $12.47 and a 200 day moving average price of $13.48. Cross Country Healthcare has a 12 month low of $10.53 and a 12 month high of $16.38. The company’s market capitalization is $428.17 million.

A number of institutional investors have recently bought and sold shares of CCRN. LS Investment Advisors LLC raised its position in Cross Country Healthcare by 484.5% in the first quarter. LS Investment Advisors LLC now owns 7,184 shares of the business services provider’s stock worth $103,000 after buying an additional 5,955 shares during the period. Globeflex Capital L P bought a new position in Cross Country Healthcare during the first quarter worth approximately $104,000. Mason Street Advisors LLC raised its position in Cross Country Healthcare by 6.9% in the first quarter. Mason Street Advisors LLC now owns 7,713 shares of the business services provider’s stock worth $111,000 after buying an additional 499 shares during the period. BNP Paribas Arbitrage SA raised its position in Cross Country Healthcare by 57.7% in the second quarter. BNP Paribas Arbitrage SA now owns 9,998 shares of the business services provider’s stock worth $129,000 after buying an additional 3,660 shares during the period. Finally, Campbell & CO Investment Adviser LLC bought a new position in Cross Country Healthcare during the first quarter worth approximately $157,000. Hedge funds and other institutional investors own 90.00% of the company’s stock.

About Cross Country Healthcare

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Earnings History and Estimates for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.